Reference 19 - Improving the Dissolution Rate of the Anticancer Drug Dabrafenib
FDA-2026-P-6541-0021Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 19 - Improving the Dissolution Rate of the Anticancer Drug Dabrafenib
- Posted
- Jun 9, 2026
- Topics